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E-mail address: l.vanderlaan@erasmusmc.nl (L.J.WRNA interference (RNAi) is widely used as a screening tool for the identiﬁcation of host genes
involved in viral infection. Due to the limitation of raw small interfering RNA (siRNA), we tested
two commonly used short hairpin RNA (shRNA) lentiviral libraries to identify host factors involved
in hepatitis C virus (HCV) infection. It was found that these shRNA library vectors caused non-speciﬁc
disturbance of HCV replication that was not due to toxicity or interferon response, but related to the
high shRNA levels disturbing the endogenous microRNA biogenesis. The high shRNA levels achieved
with these vectors reduced the levels of mature microRNAs, including miR-122 known to promote
HCV replication. Our ﬁndings extend the caution of potential off-target effects of lentiviral shRNA
libraries which appear unsuitable to screen microRNA regulated phenotypes, such as HCV
replication.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The development of RNAi libraries, which allowed performing
genome wide loss-of-function screens, has been a major step
forward for the study of gene function and resulted in identiﬁca-
tion of new genes related to various biological functions and dis-
covery of new therapeutic targets for many types of diseases [1].
The RNAi Consortium (TRC) library is the ﬁrst and the currently
most widely used lentiviral RNAi library, which uses multiple dis-
tinct short hairpin RNAs (shRNA) to knockdownmost of the known
human and mouse genes [2,3]. Broad application of this library has
already been reported in numerous publications on the identiﬁca-
tion of human disease-related genes [4–6]. The TRC library appears
to have advantages over conventional synthetic small interference
RNA (siRNA) libraries. Transfection of synthetic siRNA only evokes
transient gene silencing often accompanied with non-speciﬁc or
toxic effects, and many types of mammalian cells are ineffectivechemical Societies. Published by E
Surgery and Laboratory of
(LETIS), Erasmus MC-Univer-
30, 3015 CE, Rotterdam, The
. van der Laan).or resistant to the transfection [7]. Lentiviral vector delivery of
RNAi possesses great advantages over raw siRNA applications ow-
ing to their wide-range tropism, genomic integration property and
effective in vitro delivery.
Given the need to better understand the biology of hepatitis C
virus (HCV) infection and the search for new therapeutic targets,
several recent studies have attempted to screen host factors using
siRNA libraries [8–11]. However, mainly due to the limitation of
synthetic siRNA, host factors identiﬁed had very little overlap
and many well-established host factors were not identiﬁed (i.e.
false negatives) in those screens. Our previous studies showed that
lentiviral vectors expressing shRNAs could sequence speciﬁcally
knockdown HCV genomic RNA or host factors, whereas vectors
expressing no or irrelevant shRNAs had no signiﬁcant effect on
HCV replication [12,13].
In the present study, we have tested different lentiviral shRNA
expression systems for screening of HCV host factors and com-
pared their on-target and off-target effects. Here we report se-
quence non-speciﬁc effects of two commonly used lentiviral
shRNA libraries on HCV replication. Further analysis showed that
this off-target effect is caused by a disturbance of the microRNA
biosynthesis in the transduced cells associated with the high levellsevier B.V. All rights reserved.
1026 Q. Pan et al. / FEBS Letters 585 (2011) 1025–1030of shRNA expression by these vectors. Solutions to minimize the
off-target effects are discussed.
2. Materials and methods
2.1. Cell culture
Cell monolayers of the human embryonic kidney epithelial cell
line 293T and the human hepatoma cell line Huh7 were
maintained in Dulbecco’smodiﬁed Eaglemedium (DMEM) (Invitro-
gen–Gibco, Breda, The Netherlands) complemented with 10% v/v
fetal calf serum (Hyclone, Logan, Utah, USA), 100 IU/ml penicillin,
100 mg/ml streptomycin, and 2 mM L-glutamine (Invitrogen-Gibco)
(cDMEM). Huh7 or Huh6 cells containing a subgenomic HCV repli-
con were maintained with 250 lg/ml G418 (Sigma, Zwijndrecht,
The Netherlands). Effects on HCV replication were determined
based on luciferase activity or quantitative real time PCR.
2.2. Purchase or production of lentiviral vectors
TRC lentiviral vectors (Sigma–Aldrich) were obtained from
Erasmus Center for Biomics. Santa Cruz lentiviral RNAi vectors were
ordered from Santa Cruz Biotechnology, Inc., California, USA. Other
vectors were preserved in van der Laan or Berkhout’s lab.
2.3. In vitro vector transductions, GFP and CD81 analysis
Concentrated virus stocks were titrated using 293T cells 24 h
after infection, with transduction efﬁciency based on the number0
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Fig. 1. Sequence non-speciﬁc disturbance of HCV replication by widely used lentiviral s
cells after transducing the TRC shFKBP8 vector. However, a control vector containing
expression. (B) Set of 14 TRC shRNA vectors (pool of 4–5 vectors for each target gene) test
(C) TRC shCD81 and our home made (HM) shCD81 vector, which target the same sequ
However, the TRC vector but not our original vector showed a clear off-target effect on HC
dependent fashion as determined by qRT-PCR, but is closely accompanied with off-targe
observed in Huh6 replicon cells transduced with low dose TRC shCD81 vector and lon
knockdown of the CD81 target gene. Data of HCV and CD81 RNA expression was calculate
obtained from Santa Cruz lentiviral shRNA library showed signiﬁcant off-target effects oof GFP-positive cells as determined by ﬂowcytometry (FACS-
Calibur; BD BioSciences, Mountain View, CA, USA) after 72 h.
CD81 expression was determined using ﬂowcytometry by
staining with phycoerythrin (PE) conjugated mouse anti-human
CD81 monoclonal antibody (BD Pharmingen, San Diego, USA).
Mouse IgG1 was used as isotype-matched control antibody (BD
Pharmingen).
2.4. Selection of cells transduced with low dose TRC or home made
shCD81 lentiviral vectors
Huh7 cells were transduced with low dose TRC or home made
shCD81 lentiviral vectors, in order to generate stable cell lines with
comparable low copy number of vector integration. Since TRC
vector contains puromycin resistance gene, transduced cells were
selected by culturing in 1 lg/ml puromycin to clear the non-trans-
duced cells. Whereas our home made shCD81 vector contains GFP
reporter gene, transduced GFP positive cells were sorted by FACS
Aria sorter (BD BioSciences).
2.5. Production of RNAi conditioned medium (CM)
Huh7 cells were cultured with normal culture medium. When
cultures reached 60–70% conﬂuence, cells were un-transduced or
transduced by vector for 6 h, washed three times with PBS and
subcultured in normal medium for more than 6 days. Conditional
medium (CM) was collected from the second refreshment of the
culture medium. To avoid transfer of free LV-sh vectors or cells,
the CM was centrifuged and ﬁltered (0.25 lM pores).0
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hRNA libraries. (A) HCV replication was dramatically reduced in Huh7-ET replicon
shRNA targeting GFP also inhibited HCV replication without affecting FKBP8 gene
ed in the subsequent screening showed clear non-speciﬁc effects on HCV replication.
ence of CD81 mRNA, signiﬁcantly reduced CD81 expression at comparable levels.
V replication. (D) The TRC shCD81 vector down regulated CD81 expression in a dose-
t effects on HCV replication. (E) The non-speciﬁc effect on HCV replication was also
g-term culture after puromycin selection and it was comparable with the speciﬁc
d as the percentage of cells transduced with a control vector, LV-con. (F) Also vectors
n HCV replication. ⁄P < 0.01.
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One hundred millimolars of luciferin potassium salt (Sigma)
was added to Huh-7 ET cells and incubated for 30 min at 37 C.
Luciferase activity was quantiﬁed using a LumiStar Optima lumi-
nescence counter (BMG LabTech, Offenburg, Germany).
2.7. Quantiﬁcation of gene expression by real time RT-PCR
Cells were lysed using Trizol (Invitrogen–Gibco), RNA was pre-
cipitated using 75% EtOH and captured with a Micro RNeasy silica
column (Qiagen, Venlo, The Netherlands). RNA was quantiﬁed
using a Nanodrop ND-1000 (Wilmington, DE, USA). cDNA was pre-
pared from 1 lg total RNA using the iScript cDNA Synthesis Kit
from Bio-Rad (Bio-Rad Laboratories, Stanford, CA, USA). The cDNAs
of HCV, FKBP8, CyB, CD81 and GAPDH were quantiﬁed using real-
time PCR (MJ Research Opticon, Hercules, CA, USA) performed with
SYBR Green PCR Master Mix (Bioline USA Inc., Taunton, MA)
according to manufacturer’s instructions.
2.8. Quantiﬁcation of miRNA
The kits for total RNA isolation, cDNA preparation and real-time
PCR detection of miRNA were purchased from Exiqon, Denmark or
Applied Biosystems, USA, and the experiments were performed
according to manufacture’s guidelines. RNA was quantiﬁed using
a Nanodrop ND-1000 (Wilmington).0
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Fig. 2. The off-target effect of lentiviral shRNA libraries is independent of interferon prod
0.3 IU/ml of interferon-alpha (IFN) signiﬁcantly inhibits HCV replication by 85% ± 2 (mean
transduced with TRC LV-con or TRC LV-shRNA vectors did not show inhibition of viral rep
interferon or other antiviral cytokines/compounds after transduction of lentiviral vecto
different LV-shRNA vectors. (B) Transduction of either control or shRNA vectors did not
puromycin resistance gene from TRC vector did not circumvent the off-target effect. (D) T
replicon cells, driven by four different promoters (the polymerase III promoters U6, H1, 7S
replication, indicating that promoters by themselves are not responsible for the differen2.9. Quantiﬁcation of shRNA
The TRC shCD81 and our home made shCD81 vector express
shRNA targeting the same region of human CD81 gene (TRC
shCD81: CAAGGATGTGAAGCAGTTCTA; home made shCD81:
GGATGTGAAGCAGTTCTAT). Therefore, it allows designing a cus-
tomized kit for quantiﬁcation of both shCD81. To avoid ampliﬁca-
tion of CD81 mRNA, we specially ampliﬁed the antisense sequence
of shCD81 (UAGAACUGCUUCACAUCC) using a custom TaqMan-
based real-time PCR assay ordered from Applied Biosystems.
In order to perform a fair comparison of shCD81 expression be-
tween two vector systems, Huh7 cells were transduced with low
dose TRC or home-made shCD81 lentiviral vectors to generate sta-
ble cell lines with comparable low copy number of vector integra-
tion. Cells transduced with TRC vector were selected by culturing
in puromycin, whereas cells transduced with home-made shCD81
vector were sorted based on GFP positivity.
2.10. Quantiﬁcation of lentiviral vector integration by real time RT-
PCR
Genomic DNA of TRC or home made shCD81 transduced cells
was isolated using QIAamp DNA Blood Mini Kit (Qigan, Venlo,
The Netherlands). DNA was quantiﬁed using Nanodrop ND-1000
(Wilmington). The following primers were used to amplify the vec-
tor sequence: forward primer, 5-CTGGAAGGGCTAATTCACTC-3; re-
verse primer, 5-GGTTTCCCTTTCGCTTTCAG-3 [14]. 250 ng, 1.25 or0
0
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uction, cytotoxicity, the puromycin resistance gene or the type of promoter used. (A)
± S.D., n = 5, ⁄⁄P < 0.01), whereas conditioned medium (CM) derived from Huh7 cells
lication in Huh7-ET replicon cells, indicating no production of signiﬁcant amounts of
rs. Data presented in the shRNA-CM group is the mean of ﬁve experiments with
affect cell viability determined by MTT cell metabolism assay. (C) Deletion of the
wo sets of shRNAs, directed against HIV targets which are not expressed in the HCV
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Fig. 3. Lentiviral shRNA libraries disturb cellular miRNA biogenesis. (A) Transduction of TRC library shRNA vectors signiﬁcantly attenuated the processing of mature miR-122,
which is an established positive factor for HCV replication (mean ± S.D., n = 5, ⁄⁄P < 0.01). (B) Consistent with disturbed miR-122 maturation, the expression of the known
miR-122 target gene (CCNG1) was up-regulated (n = 5, ⁄⁄P < 0.01). (C) Attenuation of miR-122 maturation was also observed in Huh6 replicon cells with low dose TRC shCD81
vector and long-term culture after puromycin selection. Data of HCV RNA and miR-122 expression was calculated as the percentage of the control cells transduced with the
control vector, LV-con. Shown is one representative experiment of three. (D) Signiﬁcant reduction of mature miRNA was further conﬁrmed in a set of other hepatocytes
abundant miRNAs, including miR-148a, miR-191, miR-192, miR-194 and miR-296. ⁄P < 0.05, ⁄⁄P < 0.01.
1028 Q. Pan et al. / FEBS Letters 585 (2011) 1025–10302.5 lg of genomic DNA with SYBR Green PCR Master Mix (Bioline
USA Inc.) and primer were used per RT-PCR reaction to determine
the relative copy number of integrated lentiviral vector.
2.11. Statistical analysis
Statistical analysis was performed by using either matched pair
non-parametric test (Wilcoxon signed-rank test) or the non-paired,
non-parametric test (Mann–Whitney test) using GraphPad Prism
software. P-values less than 0.05 were considered as statistically
signiﬁcant.
3. Results and discussion
The TRC lentiviral shRNA library (Sigma–Aldrich, St. Louis, MO,
USA) [3] is based on the third-generation self-inactivating lentivi-
ral vector contains a shRNA cassette driven by the human polymer-
ase III promoter U6 and the puromycin resistance gene (puromycin
n-acetyl transferase) driven by the PGK promoter element. Using
these vectors, long-term gene silencing can be achieved at low
multiplicity of infection (MOI) transduction by puromycin selec-
tion of stable vector-integrated cells. We ﬁrst screened in the
established HCV subgenomic replicon model, Huh7-ET, which con-
tains HCV non-structural sequences and a luciferase reporter gene
[15]. Viral replication was monitored by measuring luciferase
activity. As expected, a pool of ﬁve different shRNA vectors target-
ing a known HCV host factor, FKBP8 [16], resulted in knockdown of
FKBP8 gene expression and inhibition of HCV replication (Fig. 1A).
However, a control vector containing shRNA targeting greenﬂuorescent protein (shGFP), which is not expressed in these HCV
replicon cells, unexpectedly resulted in inhibition of HCV replica-
tion without affecting FKBP8 gene expression (Fig. 1A). Surpris-
ingly, any set of shRNA vectors we tested from the TRC library
(14 target genes without known relation to HCV replication),
evoked a signiﬁcant inhibition of HCV replication compared to un-
treated replicon cells or cells treated with the control vector (LV-
con) without shRNA cassette (Fig. 1B). The tetraspanin CD81 is
known to be involved in HCV viral entry but not viral replication.
Direct comparison of our home-made shCD81 vector [12,13] and
the TRC shCD81 vector containing the exact same CD81 target se-
quence showed both vectors had similar efﬁcacy in reducing CD81
gene expression, however, only the TRC vector affected HCV repli-
cation (Fig. 1C). The off-target and the gene-speciﬁc silencing ef-
fects of the TRC shCD81 vector had similar dose-dependency for
a range of MOI (Fig. 1D). The off-target effect was even seen after
four weeks of puromycin selection of cells with low vector integra-
tion rates (Fig. 1E). This was tested in another hepatoma cell line,
Huh6 replicon, a model that is more suitable for long-term main-
taining HCV replication in culture [17]. These results suggest that
optimization of the dose of the shRNA vector is not able to circum-
vent the off-target effect. We further tested another independent
lentiviral shRNA library commercially available from Santa Cruz
Biotechnology (http://www.scbt.com/gene_silencers.html.) For
each target gene, pools of three to ﬁve individual vectors are pro-
vided, each containing different shRNA species driven by the same
H1, human polymerase III promoter. As shown in Fig. 1F, all the
vectors induced speciﬁc silencing of target genes by 70–80% but
also evoked off-target inhibition of HCV replication.
Q. Pan et al. / FEBS Letters 585 (2011) 1025–1030 1029It is known that expression of double-stranded RNA can induce
the production of type I interferons via activation of PKR. In order
to exclude the possible induction of interferon as well as other par-
acrine antiviral cytokines/compounds by the TRC shRNA vectors,
we collected culture medium from transduced Huh7 cells and
determined the antiviral activity in HCV replicon cells. As shown
in Fig. 2A, conditioned medium of transduced cells had no effect
on HCV replication suggesting that no signiﬁcant amounts of inter-
feron or other antiviral cytokines/compounds are produced. Also
the number of viable cells was not changed after transduction as
measured by MTT conversion assay (Fig. 2B). One clear difference
between our vectors and the vectors from the TRC and Santa Cruz
libraries is the fact that these latter ones contain the puromycin
resistance gene. To investigate whether the puromycin resistance
gene cause the inhibition of HCV replication, a modiﬁed version
of the TRC shGFP vector was made by removing the coding se-
quence of the puromycin resistance gene. As shown in Fig. 2C, this
modiﬁed lentiviral vector had a similar effect on HCV replication as
the wild type shGFP vector. An alternative explanation for the dif-
ferent off-target effects of shRNA vectors is the use of a particular
promoter element, as it was reported that shRNA expression levels
could signiﬁcantly differ between, for instance, the U6 and H1 pro-
moters [18]. To investigate whether different promoters cause dis-
tinct off-target effects, two sets of shRNAs vectors were tested with
four different promoters (the polymerase III promoters U6, H1, 7SK
and the polymerase II, U1) [19]. The shRNAs were directed against
the Pol and Nef HIV sequences which are not present in the HCV
replicon cells. As shown in Fig. 2D, none of vectors induced any
inhibition of HCV replication, suggesting that a difference in0
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Fig. 4. Over-expression of shRNA by the TRC library vector causes disturbance of mature m
lentiviral vectors were selected by puromycin resistance or cell sorting, respectively. (A)
(mean ± S.D., n = 4). (B) The shCD81 expression level was signiﬁcantly higher in TRC vect
vector transduced cells. (C) Accordingly, miR-122 expression was signiﬁcantly down-r
Increasing doses of the vector input of TRC shCD81 vector resulted in increased level of s
experiment of two.promoter does not, by it self, explain the difference in off-target
effects.
Previous study has reported that adeno-associated virus deliv-
ered shRNA in certain context could over-saturate the cellular
microRNA pathways [20]. Numerous studies have consistently
shown that HCV replication is tightly regulated by the endogenous
microRNA, miR-122 [21,22], and treatment of chronically infected
chimpanzees with a locked nucleic acid (LNA)-modiﬁed oligonu-
cleotide complementary to miR-122 leads to long-lasting suppres-
sion of HCV viremia [23]. Therefore, we investigated the effects of
library shRNA vectors on the miRNA biogenesis. As shown in
Fig. 3A, we found that in transduced cells levels of mature miR-
122 (detected by mature miRNA speciﬁc RT-PCR) were signiﬁ-
cantly reduced by 68% ± 10 (mean ± S.D., n = 7, P < 0.01), which
was accompanied by a more than threefold increased expression
of cyclin G1 (CCNG1), known to be negatively regulated by miR-
122 [24] (Fig. 3B). Similar results were obtained with cells having
low vector integration rates selected by puromycin treatment,
showing long-term suppression of miR-122 coinciding with a per-
sistent reduction of HCV replication (Fig. 3C). Disturbance of miR-
NA biogenesis was not restricted to miR-122 but also seen for ﬁve
other hepatic abundant miRNAs (Fig. 3D).
To further investigate the cause of miRNA biogenesis distur-
bances, we directly compared shRNA expression levels in cells
transduced with the TRC shCD81 vector or our home-made shCD81
vectors using a customized quantitative RT-PCR assay. The shRNA
of both vectors target the same region of CD81 mRNA, allowing
direct comparison of expression levels. Both vectors resulted in a
similar number of integrated vectors per cell (1.0 vs 1.8 copy0
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Comparable CD81 knockdown by TRC or home-made shCD81 vectors was observed
or transduced cells (12.6-fold ± 0.8 S.D., n = 4, ⁄P < 0.01) as compared to home-made
egulated in TRC shCD81 cells and not the HM shCD81 cells (n = 4, ⁄P < 0.01). (D)
hCD81 and reversely decreased the levels of miR-122. Shown is one representative
1030 Q. Pan et al. / FEBS Letters 585 (2011) 1025–1030numbers per cells, P = 0.51). As shown in Fig. 4A, both vectors re-
sulted in a comparable knockdown of CD81 cell surface expression.
However, the TRC shCD81 vector resulted in an over 10-fold higher
expression of shRNA then our own shCD81 vector (Fig. 4B). Consis-
tently, signiﬁcant lower expression of miR-122 was observed in the
TRC transduced cells (Fig. 4C). Apparently, the commercial lentivi-
ral shRNA vectors have been optimized for efﬁcient shRNA expres-
sion intended to maximize the knockdown efﬁciency of the target
genes. Additional experiments were performed to conﬁrm the rela-
tion between shCD81 and miR-122 level. As shown in Fig. 4D, esca-
lating doses of the vector input resulted in an increased level of
shCD81 and, reversely, a decreased level of miR-122. This is consis-
tent with the earlier observation that increasing dose of TRC shRNA
vectors results in increasing inhibition of HCV replication (Fig. 1D).
Combined, these results indicate that over-expression of shRNA af-
fects the miRNA levels, likely by causing saturation of the cellular
components of the miRNA biosynthesis pathway including expor-
tin-5 and Argonaute proteins [25].
In conclusion, we found that two widely used lentiviral shRNA
libraries have unexpected effects on HCV replication, due to the dis-
turbance of endogenous miRNA production by high the levels of
shRNAs. The model system we have used maybe particular sensi-
tive to regulation bymiRNA, but these ﬁndings raise concerns about
potential off-target effects seen in lentiviral RNAi screens due to ef-
fects onmiRNA regulated phenotypes. Therefore, based on our ﬁnd-
ings, caution should be taken in interpretation and validation of
positive hits obtained in lentiviral RNAi screening, and appropriate
control vectors should be tested to exclude effects on miRNA pro-
cessing. A solution to this problem is proposed to balance the opti-
mization of shRNA expression levels in order to obtain effective
RNAi and the minimization of disturbance of miRNA levels.
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